Piramal Pharma reported results for second quarter ended September 30, 2022.
The company has reported fall of 48.11% in its net profit at Rs 47.33 crore for Q2FY23 as compared to Rs 91.22 crore for the corresponding quarter previous year. However, total income of the company increased by 9.62% to Rs 946.57 crore for the quarter under review as compared to Rs 863.52 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported net loss of Rs 37.34 crore for the quarter under review as compared to net profit of Rs 36.56 crore for the same quarter in the previous year. However, total income of the company increased by 10.70% to Rs 1,766.23 crore for the quarter under review as compared to Rs 1,595.45 crore for the same quarter in the previous year.
